Robert Hazlett
Robert Hazlett
billion change company critical growth
It's at the margin. It's $3 billion and change of a $50 billion company, so it's not inconsequential, but is it critical to the growth of the company going forward? No.
investors meaningful risk
For investors in Pfizer, this is a meaningful event. This risk has been a significant overhang for some time.
appears challenge knew
We knew 2003 was going to be a challenge, but it appears it's going to be more of a challenge than we expected.